Sproule Rizwana F
VP Regulatory Affairs at Kite Pharma, Inc.
- Sold, on record
- $6.2M
- Dollars the filings state
- Form 4 sales
- 11
- Latest Mar 15, 2016
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Kite Pharma, Inc.VP Regulatory Affairs
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Kite Pharma, Inc.UnusualAug 17 2015
Sold 9,567 shares at $60.88 ($582k)
Sproule Rizwana F, VP Regulatory Affairs
Sold 84.9% of holdings ($686k position)1,695 shares left1x usual sizeFiling
- 2 Form 4 sale Kite Pharma, Inc.UnusualSep 15 +29 days
Sold 9,567 shares at $64.36 ($616k)
Sproule Rizwana F, VP Regulatory Affairs
Sold 76.5% of holdings ($805k position)2,941 shares left1x usual sizeFiling
- 3 Form 4 sale Kite Pharma, Inc.UnusualOct 15 +30 days
Sold 9,567 shares at $62.58 ($599k)
Sproule Rizwana F, VP Regulatory Affairs
Sold 76.5% of holdings ($783k position)2,941 shares left1x usual sizeFiling
- 4 Form 4 sale Kite Pharma, Inc.UnusualNov 16 +32 days
Sold 9,567 shares at $78.13 ($748k)
Sproule Rizwana F, VP Regulatory Affairs
Sold 76.5% of holdings ($977k position)2,941 shares left1x usual sizeFiling
- 5 Form 4 sale Kite Pharma, Inc.UnusualDec 15 +29 days
Sold 9,567 shares at $63.76 ($610k)
Sproule Rizwana F, VP Regulatory Affairs
Sold 76.5% of holdings ($798k position)2,941 shares left1x usual sizeFiling
- 6 Form 4 sale Kite Pharma, Inc.UnusualJan 19 +35 days
Sold 9,567 shares at $55.49 ($531k)
Sproule Rizwana F, VP Regulatory Affairs
Sold 52.3% of holdings ($1M position)8,741 shares left1x usual sizeFiling
- 7 Form 4 sale Kite Pharma, Inc.UnusualFeb 17 +29 days
Sold 9,567 shares at $45.08 ($431k)
Sproule Rizwana F, VP Regulatory Affairs
Sold 52.3% of holdings ($825k position)8,741 shares left1x usual sizeFiling
- 8 Form 4 sale Kite Pharma, Inc.UnusualMar 15 +27 days
Sold 8,500 shares at $45.27 ($385k)
Sproule Rizwana F, VP Regulatory Affairs
Sold 45.4% of holdings ($847k position)10,211 shares left0.9x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (11)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Mar 15, 2016 | Kite Pharma, Inc. | VP Regulatory Affairs | Form 4 sale | 8,500 | $385k | 45.4% | Unusual | SEC |
| Feb 17, 2016 | Kite Pharma, Inc. | VP Regulatory Affairs | Form 4 sale | 9,567 | $431k | 52.3% | Unusual | SEC |
| Jan 19, 2016 | Kite Pharma, Inc. | VP Regulatory Affairs | Form 4 sale | 9,567 | $531k | 52.3% | Unusual | SEC |
| Dec 15, 2015 | Kite Pharma, Inc. | VP Regulatory Affairs | Form 4 sale | 9,567 | $610k | 76.5% | Unusual | SEC |
| Nov 16, 2015 | Kite Pharma, Inc. | VP Regulatory Affairs | Form 4 sale | 9,567 | $748k | 76.5% | Unusual | SEC |
| Oct 15, 2015 | Kite Pharma, Inc. | VP Regulatory Affairs | Form 4 sale | 9,567 | $599k | 76.5% | Unusual | SEC |
| Sep 15, 2015 | Kite Pharma, Inc. | VP Regulatory Affairs | Form 4 sale | 9,567 | $616k | 76.5% | Unusual | SEC |
| Aug 17, 2015 | Kite Pharma, Inc. | VP Regulatory Affairs | Form 4 sale | 9,567 | $582k | 84.9% | Unusual | SEC |
| Jul 15, 2015 | Kite Pharma, Inc. | VP Regulatory Affairs | Form 4 sale | 9,567 | $688k | 84.9% | Unusual | SEC |
| Jun 15, 2015 | Kite Pharma, Inc. | VP Regulatory Affairs | Form 4 sale | 9,567 | $545k | 84.9% | Unusual | SEC |
| May 15, 2015 | Kite Pharma, Inc. | VP Regulatory Affairs | Form 4 sale | 9,567 | $480k | 84.9% | Unusual | SEC |